{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:39:54Z","timestamp":1793353194097,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["03ZZ0813E"],"award-info":[{"award-number":["03ZZ0813E"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["03ZZ0813E"],"award-info":[{"award-number":["03ZZ0813E"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Airway inflammation and chronic lung infections in cystic fibrosis (CF) patients are mostly caused by bacteria, e.g. <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (PA). The role of fungi in the CF lung is still not well elucidated, but evidence for a harmful and complex role is getting stronger. The most common filamentous fungus in CF is <jats:italic>Aspergillus fumigatus<\/jats:italic> (AF). Age and continuous antibiotic treatment have been discussed as risk factors for AF colonisation but did not differentiate between transient and persistent AF colonisation. Also, the impact of co-colonisation of PA and AF on lung function is still under investigation. Data from patients with CF registered in the German Cystic Fibrosis Registry database in 2016 and 2017 were retrospectively analysed, involving descriptive and multivariate analysis to assess risk factors for transient or persistent AF colonisation. Age represented an independent risk factor for persistent AF colonisation. Prevalence was low in children less than ten years, highest in the middle age and getting lower in higher age (\u2265\u200950\u00a0years). Continuous antibiotic lung treatment was significantly associated with AF prevalence in all age groups. CF patients with chronic PA infection had a lower lung function (FEV1%predicted), which was not influenced by an additional AF colonisation. AF colonisation without chronic PA infection, however, was significantly associated with a lower function, too. Older age up to 49\u00a0years and continuous antibiotic use were found to be the main risk factors for AF permanent colonisation. AF might be associated with decrease of lung function if not disguised by chronic PA infection.<\/jats:p>","DOI":"10.1038\/s41598-020-75886-w","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T11:03:36Z","timestamp":1604487816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function"],"prefix":"10.1038","volume":"10","author":[{"given":"Uta","family":"D\u00fcesberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wosniok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Naehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patience","family":"Eschenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"issue":"2","key":"75886_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ppul.10127","volume":"34","author":"J Emerson","year":"2002","unstructured":"Emerson, J. et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr. Pulmonol. 34(2), 91\u2013100. https:\/\/doi.org\/10.1002\/ppul.10127 (2002).","journal-title":"Pediatr. Pulmonol."},{"key":"75886_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","volume":"151","author":"MW Konstan","year":"2007","unstructured":"Konstan, M. W. et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J. Pediatr. 151, 134\u2013139. https:\/\/doi.org\/10.1016\/j.jpeds.2007.03.006 (2007).","journal-title":"J. Pediatr."},{"key":"75886_CR3","unstructured":"German Cystic Fibrosis Registry, Annual Report 2018. https:\/\/www.muko.info\/fileadmin\/user_upload\/angebote\/qualitaetsmanagement\/register\/berichtsbaende\/annual_report_2018.pdf"},{"key":"75886_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fmicb.2015.00089","volume":"6","author":"LD Nguyen","year":"2015","unstructured":"Nguyen, L. D., Viscogliosi, E. & Delhaes, L. The lung mycobiome: an emerging field of the human respiratory microbiome. Front. Microbiol. 6, 89. https:\/\/doi.org\/10.3389\/fmicb.2015.00089 (2015).","journal-title":"Front. Microbiol."},{"issue":"1","key":"75886_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11046-017-0184-y","volume":"183","author":"A Singh","year":"2018","unstructured":"Singh, A. et al. Fungal pathogens in CF airways: leave or treat?. Mycopathologia 183(1), 119\u2013137. https:\/\/doi.org\/10.1007\/s11046-017-0184-y (2018).","journal-title":"Mycopathologia"},{"issue":"1","key":"75886_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11046-017-0199-4","volume":"183","author":"C Schwarz","year":"2018","unstructured":"Schwarz, C. et al. Invasive pulmonary fungal infections in cystic fibrosis. Mycopathologia 183(1), 33\u201343. https:\/\/doi.org\/10.1007\/s11046-017-0199-4 (2018).","journal-title":"Mycopathologia"},{"issue":"1","key":"75886_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11046-017-0182-0","volume":"183","author":"C Schwarz","year":"2018","unstructured":"Schwarz, C. et al. Progress in definition, prevention and treatment of fungal infections in Cystic Fibrosis. Mycopathologia 183(1), 21\u201332. https:\/\/doi.org\/10.1007\/s11046-017-0182-0 (2018).","journal-title":"Mycopathologia"},{"issue":"1","key":"75886_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11046-017-0190-0","volume":"183","author":"C Brandt","year":"2018","unstructured":"Brandt, C. et al. Aspergillus bronchitis in patients with Cystic Fibrosis. Mycopathologia 183(1), 61\u201369. https:\/\/doi.org\/10.1007\/s11046-017-0190-0 (2018).","journal-title":"Mycopathologia"},{"issue":"2","key":"75886_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jcf.2018.08.012","volume":"18","author":"C Schwarz","year":"2019","unstructured":"Schwarz, C. et al. Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis. J. Cyst. Fibros. 18(2), 227\u2013232. https:\/\/doi.org\/10.1016\/j.jcf.2018.08.012 (2019).","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"75886_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcf.2018.10.001","volume":"18","author":"L Delhaes","year":"2019","unstructured":"Delhaes, L. et al. Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study \u201cMFIP\u201d. J. Cyst. Fibros 18(2), 212\u2013220. https:\/\/doi.org\/10.1016\/j.jcf.2018.10.001 (2019).","journal-title":"J. Cyst. Fibros"},{"issue":"2","key":"75886_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/13693786.2013.792438","volume":"52","author":"L Masoud-Landgraf","year":"2014","unstructured":"Masoud-Landgraf, L. et al. Modified culture method detects a high diversity of fungal species in cystic fibrosis patients. Med. Mycol. 52(2), 179\u2013186. https:\/\/doi.org\/10.3109\/13693786.2013.792438 (2014).","journal-title":"Med. Mycol."},{"issue":"2","key":"75886_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jcf.2018.11.012","volume":"18","author":"TGP Engel","year":"2019","unstructured":"Engel, T. G. P. et al. Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study. J. Cyst. Fibros 18(2), 221\u2013226. https:\/\/doi.org\/10.1016\/j.jcf.2018.11.012 (2019).","journal-title":"J. Cyst. Fibros"},{"issue":"1","key":"75886_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/13693780903127506","volume":"48","author":"Y Nagano","year":"2010","unstructured":"Nagano, Y. et al. Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. Med. Mycol. 48(1), 166\u2013176. https:\/\/doi.org\/10.3109\/13693780903127506 (2010).","journal-title":"Med. Mycol."},{"issue":"2","key":"75886_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jcf.2009.11.010","volume":"9","author":"CR Sudfeld","year":"2010","unstructured":"Sudfeld, C. R. et al. Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. J. Cyst. Fibros 9(2), 110\u2013116. https:\/\/doi.org\/10.1016\/j.jcf.2009.11.010 (2010).","journal-title":"J. Cyst. Fibros"},{"key":"75886_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13693780802609604","volume":"47","author":"M Pihet","year":"2009","unstructured":"Pihet, M. et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis\u2014a review. Med. Mycol. 47, 387\u2013397. https:\/\/doi.org\/10.1080\/13693780802609604 (2009).","journal-title":"Med. Mycol."},{"issue":"1","key":"75886_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11046-017-0205-x","volume":"183","author":"C Schwarz","year":"2018","unstructured":"Schwarz, C. et al. Organization of patient management and fungal epidemiology in Cystic Fibrosis. Mycopathologia 183(1), 7\u201319. https:\/\/doi.org\/10.1007\/s11046-017-0205-x (2018).","journal-title":"Mycopathologia"},{"issue":"12","key":"75886_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/cea.12595","volume":"45","author":"VN Maturu","year":"2015","unstructured":"Maturu, V. N. & Agarwal, R. Prevalence of Ascypergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin. Exp. Allergy 45(12), 1765\u20131778. https:\/\/doi.org\/10.1111\/cea.12595 (2015).","journal-title":"Clin. Exp. Allergy"},{"key":"75886_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1378\/chest.130.1.222","volume":"130","author":"D Shoseyov","year":"2006","unstructured":"Shoseyov, D. et al. Aspergillus bronchitis in cystic fibrosis. Chest 130, 222\u2013226. https:\/\/doi.org\/10.1378\/chest.130.1.222 (2006).","journal-title":"Chest"},{"issue":"5","key":"75886_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1378\/chest.12-1363","volume":"143","author":"CG Baxter","year":"2013","unstructured":"Baxter, C. G. et al. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest 143(5), 1351\u20131357. https:\/\/doi.org\/10.1378\/chest.12-1363 (2013).","journal-title":"Chest"},{"issue":"5","key":"75886_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","volume":"17","author":"G Hong","year":"2018","unstructured":"Hong, G. et al. Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis. J. Cyst. Fibros 17(5), 624\u2013630. https:\/\/doi.org\/10.1016\/j.jcf.2018.01.008 (2018).","journal-title":"J. Cyst. Fibros"},{"issue":"6","key":"75886_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/pai.12590","volume":"27","author":"A Thronicke","year":"2016","unstructured":"Thronicke, A. et al. Allergic bronchopulmonary aspergillosis is associated with pet ownership in cystic fibrosis. Pediatr. Allergy Immunol. 27(6), 597\u2013603. https:\/\/doi.org\/10.1111\/pai.12590 (2016).","journal-title":"Pediatr. Allergy Immunol."},{"key":"75886_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12890-017-0416-4","volume":"17","author":"E Reece","year":"2017","unstructured":"Reece, E. et al. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm. Med. 17, 70. https:\/\/doi.org\/10.1186\/s12890-017-0416-4 (2017).","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"75886_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jcf.2016.01.004","volume":"15","author":"A Hector","year":"2016","unstructured":"Hector, A. et al. Microbial colonization and lung function in adolescents with cystic fibrosis. J. Cyst. Fibros 15(3), 340\u2013349. https:\/\/doi.org\/10.1016\/j.jcf.2016.01.004 (2016).","journal-title":"J. Cyst. Fibros"},{"key":"75886_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jof5020048","author":"B Briard","year":"2019","unstructured":"Briard, B. et al. Interactions between Aspergillus fumigatus and pulmonary bacteria: current state of the field, new data, and future perspective. J. Fungi (Basel) https:\/\/doi.org\/10.3390\/jof5020048 (2019).","journal-title":"J. Fungi (Basel)"},{"key":"75886_CR25","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3389\/fmicb.2018.01205","volume":"9","author":"E Reece","year":"2018","unstructured":"Reece, E. et al. Aspergillus fumigatus inhibits Pseudomonas aeruginosa in co-culture: implications of a mutually antagonistic relationship on virulence and inflammation in the CF airway. Front. Microbiol. 9, 1205. https:\/\/doi.org\/10.3389\/fmicb.2018.01205 (2018).","journal-title":"Front. Microbiol."},{"issue":"4","key":"75886_CR26","doi-asserted-by":"publisher","first-page":"e36313","DOI":"10.1371\/journal.pone.0036313","volume":"7","author":"L Delhaes","year":"2012","unstructured":"Delhaes, L. et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community\u2013implications for therapeutic management. PLoS ONE 7(4), e36313. https:\/\/doi.org\/10.1371\/journal.pone.0036313 (2012).","journal-title":"PLoS ONE"},{"key":"75886_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150155","author":"F Shirazi","year":"2016","unstructured":"Shirazi, F. et al. Biofilm filtrates of Pseudomonas aeruginosa strains isolated from Cystic Fibrosis patients inhibit preformed Aspergillus fumigatus biofilms via apoptosis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0150155 (2016).","journal-title":"PLoS ONE"},{"issue":"2","key":"75886_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1574-6968.2010.02130.x","volume":"313","author":"E Mowat","year":"2010","unstructured":"Mowat, E. et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol. Lett. 313(2), 96\u2013102. https:\/\/doi.org\/10.1111\/j.1574-6968.2010.02130.x (2010).","journal-title":"FEMS Microbiol. Lett."},{"key":"75886_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00103-012-1486-3","volume":"55","author":"H H\u00f6lling","year":"2012","unstructured":"H\u00f6lling, H. et al. The KiGGS Study. Nationwide representative longitudinal and cross-sectional study on the health of children and adolescents within the framework of health monitoring at the Robert Koch Institute. Bundesgesundheitsbl 55, 836\u2013842. https:\/\/doi.org\/10.1007\/s00103-012-1486-3 (2012).","journal-title":"Bundesgesundheitsbl"},{"issue":"17","key":"75886_CR30","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1055\/s-0030-1253666","volume":"135","author":"C Hemmelmann","year":"2010","unstructured":"Hemmelmann, C. et al. Percentiles of bBody Mass Index of 18\u201380-year-old German adults based on data from the second national nutrition survey. Dtsch. Med. Wochenschr. 135(17), 848\u2013852. https:\/\/doi.org\/10.1055\/s-0030-1253666 (2010).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"75886_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TWR Lee","year":"2003","unstructured":"Lee, T. W. R. et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cystic. Fibros 2, 29\u201334. https:\/\/doi.org\/10.1016\/S1569-1993(02)00141-8 (2003).","journal-title":"J. Cystic. Fibros"},{"key":"75886_CR32","doi-asserted-by":"publisher","first-page":"105683","DOI":"10.1016\/j.mimet.2019.105683","volume":"164","author":"E Reece","year":"2019","unstructured":"Reece, E. et al. The prevalence of Aspergillus fumigatus in early cystic fibrosis disease is underestimated by culture-based diagnostic methods. J. Microbiol. Methods 164, 105683. https:\/\/doi.org\/10.1016\/j.mimet.2019.105683 (2019).","journal-title":"J. Microbiol. Methods"},{"issue":"5","key":"75886_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/mmy\/myv119","volume":"54","author":"RV Saunders","year":"2016","unstructured":"Saunders, R. V. et al. Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lung function. Med. Mycol. 54(5), 537\u2013543. https:\/\/doi.org\/10.1093\/mmy\/myv119 (2016).","journal-title":"Med. Mycol."},{"key":"75886_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1465-9921-11-140","volume":"11","author":"DM Green","year":"2010","unstructured":"Green, D. M. et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir. Res. 11, 140. https:\/\/doi.org\/10.1186\/1465-9921-11-140 (2010).","journal-title":"Respir. Res."},{"issue":"3","key":"75886_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1164\/rccm.201106-1027OC","volume":"185","author":"N Chaudhary","year":"2012","unstructured":"Chaudhary, N. et al. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am. J. Respir. Crit. Care Med. 185(3), 301\u2013310. https:\/\/doi.org\/10.1164\/rccm.201106-1027OC (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"75886_CR36","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","volume":"195","author":"KB Hisert","year":"2017","unstructured":"Hisert, K. B. et al. Restoring Cystic Fibrosis Transmembrane Conductance Regulator function reduces airway bacteria and inflammation in people with Cystic Fibrosis and chronic lung infections. Am. J. Respir. Crit. Care Med. 195(12), 1617\u20131628. https:\/\/doi.org\/10.1164\/rccm.201609-1954OC (2017).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75886-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:16:53Z","timestamp":1670365013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75886-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18999"}}